Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (121-130 of 662) with videos related to

Pageof 67
Sort By:
American Journal of Hematology|October 9, 2014
All systems redParas Karmacharya, Anthony A Donato, Madan Raj Aryal, et al.
International Archives of Allergy and Immunology|May 23, 2022
Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
International Archives of Allergy and Immunology|May 5, 2012
Glucocorticosteroids rescue basophils from dasatinib-augmented immunoglobulin E-mediated histamine releaseHarald Herrmann, Katharina Blatt, Viviane Ghanim, et al.
British Journal of Haematology|February 22, 2017
The JAK2 blocker TG101209 is a potent inhibitor of clonogenic progenitor cell growth in patients with chronic myeloid leukaemiaSvitlana Demyanets, Eva Jaeger, Eleonore Pablik, et al.
Leukemia & Lymphoma|October 6, 2007
Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implicationsMichael Pfeilstöcker, Heidrun Karlic, Thomas Nösslinger, et al.
Expert Opinion on Biological Therapy|October 16, 2020
Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurinJason Gotlib, Hanneke C Kluin-Nelemans, Cem Akin, et al.
Blood|December 20, 2014
Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitorsPeter Valent, Emir Hadzijusufovic, Gerit-Holger Schernthaner, et al.
Leukemia Research|December 3, 2014
Chronic mast cell leukemia: a novel leukemia-variant with distinct morphological and clinical featuresPeter Valent, Karl Sotlar, Wolfgang R Sperr, et al.
Cancer Research|January 25, 2013
Heterogeneity of neoplastic stem cells: theoretical, functional, and clinical implicationsPeter Valent, Dominique Bonnet, Stefan Wöhrer, et al.
Wiener Klinische Wochenschrift|September 20, 2002
[Aleukemic mast cell leukemia (formerly: "malignant mastocytosis"): an extremely rare form of leukemia. A case report and simultaneously a contribution to revised classification of mastocytosis]Hans-Peter Horny, Manuela Krokowski, Alfred C Feller, et al.
Pageof 67

Showing results (121-130 of 662) with videos related to

Sort By:
Pageof 67
American Journal of Hematology|October 9, 2014
All systems redParas Karmacharya, Anthony A Donato, Madan Raj Aryal, et al.
International Archives of Allergy and Immunology|May 23, 2022
Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
International Archives of Allergy and Immunology|May 5, 2012
Glucocorticosteroids rescue basophils from dasatinib-augmented immunoglobulin E-mediated histamine releaseHarald Herrmann, Katharina Blatt, Viviane Ghanim, et al.
British Journal of Haematology|February 22, 2017
The JAK2 blocker TG101209 is a potent inhibitor of clonogenic progenitor cell growth in patients with chronic myeloid leukaemiaSvitlana Demyanets, Eva Jaeger, Eleonore Pablik, et al.
Leukemia & Lymphoma|October 6, 2007
Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implicationsMichael Pfeilstöcker, Heidrun Karlic, Thomas Nösslinger, et al.
Expert Opinion on Biological Therapy|October 16, 2020
Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurinJason Gotlib, Hanneke C Kluin-Nelemans, Cem Akin, et al.
Blood|December 20, 2014
Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitorsPeter Valent, Emir Hadzijusufovic, Gerit-Holger Schernthaner, et al.
Leukemia Research|December 3, 2014
Chronic mast cell leukemia: a novel leukemia-variant with distinct morphological and clinical featuresPeter Valent, Karl Sotlar, Wolfgang R Sperr, et al.
Cancer Research|January 25, 2013
Heterogeneity of neoplastic stem cells: theoretical, functional, and clinical implicationsPeter Valent, Dominique Bonnet, Stefan Wöhrer, et al.
Wiener Klinische Wochenschrift|September 20, 2002
[Aleukemic mast cell leukemia (formerly: "malignant mastocytosis"): an extremely rare form of leukemia. A case report and simultaneously a contribution to revised classification of mastocytosis]Hans-Peter Horny, Manuela Krokowski, Alfred C Feller, et al.
Pageof 67